GlassScriptPhysician profile
Mia C Mong
NPI 1053888339
$5,337.92
in general payments reported to CMS, 2019-2025
24 companies · $470 in 2025
The $470 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $625 · 2022: $734 · 2023: $613 · 2024: $2,896 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,398 · Travel and Lodging: $1,231 · Consulting Fee: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,397.62 |
| Travel and Lodging | $1,230.76 |
| Consulting Fee | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,313.66 | 2024 | Symplicity G3 |
| Recor Medical INC | $563.15 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Amgen INC. | $279.30 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $236.27 | 2022-2023 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $225.48 | 2022-2024 | Camzyos, Eliquis |
| Abiomed | $217.40 | 2022-2023 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $214.62 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $212.52 | 2021-2022 | |
| Boston Scientific Corporation | $142.10 | 2024 | Watchman Flx |
| Novartis Pharmaceuticals Corporation | $124.93 | 2022-2025 | |
| Scpharmaceuticals INC. | $113.67 | 2023-2024 | |
| Pfizer INC. | $104.52 | 2021-2023 | |
| Alexion Pharmaceuticals, INC. | $104.15 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $92.48 | 2022-2023 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $74.19 | 2021-2024 | Farxiga |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $65.43 | 2024 | Assurity |
| Lexicon Pharmaceuticals, INC. | $65.40 | 2023-2024 | Inpefa |
| Merck Sharp & Dohme LLC | $48.20 | 2023-2024 | Verquvo |
| Amarin Pharma, INC. | $34.65 | 2021 | |
| Baxter Healthcare | $34.00 | 2023 | Hillrom - Life 2000 Ventilation System |
| Cvrx, INC. | $24.85 | 2021 | |
| Gilead Sciences, INC. | $17.21 | 2022 | |
| Abbvie INC. | $16.09 | 2022 | |
| Esperion Therapeutics, INC. | $13.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mia Mong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.